Cheng Zhang received his Ph.D. from the University of California at San Diego. Postdoc at MIT with Nobel Laureate Prof. Gobind Khorana. He is s Professor Level Senior Engineer; Visiting Professor at Sichuan University. 30-year biopharmaceutical research and development experiences at MIT, NIH, Millennium Pharmaceuticals, and Amgen. Dr. Cheng joined GMAX in 2011 and has been leading the GPCR/M-body research effort since then. Rich experience in developing antibody drugs targeting complex receptors. 28 publications and 17 patents.